Share：
Share this content in WeChat
X
[Chinese][PDF]1019114
• Clinical Article •
Clinical and MRI analysis of hepatic and cerebral hepatolenticular degeneration
ZHAO Tieniu  LIAN Yuanshu  HU Xuemei  TAN Wenting  DENG Guohong  LIU He  HU Xiaofei 

Cite this article as: Zhao TN, Lian YS, Hu XＭ, et al. Clinical and MRI analysis of hepatic and cerebral hepatolenticular degeneration [J]. Chin J Magn Reson Imaging, 2021, 12(3): 1-5. DOI:10.12015/issn.1674-8034.2021.03.001.


[Abstract] Objective To investigate the disparity of the imaging features, fundus examination and laboratory examination between hepatic and cerebral hepatolenticular degeneration [Wilson disease (WD)]. Materials andMethods The imaging features and clinical data, presentation, laboratory examinations of 89 patients with hepatolenticular degeneration diagnosed by gene test in the first affiliated hospital of army medical university hospital between 2009—2019 were collected and analyzed retrospectively. MRI abnormalities were rated using standardized methods. Comparison of clinical measures and imaging scores between different types of hepatolenticular degeneration patients were performed.Results There was no significant difference in the positive rate of KF between brain type and liver type (P=0.946＞0.05), but the content of copper and ceruloplasmin in patients of brain type were significant lower than those in patients of liver type (P＜0.001). The abnormal signal rate of brain MRI except pallidum, thalamus and cerebellum in patients of brain type was higher than that in patients of liver type (P=0.043, 0.013＜0.05). There was no significant difference between the two types of patients in the abnormal signal range of globus pallidus and thalamus (P＞0.05), while the cumulative score of patients with brain type was significantly higher than that of patients with liver type (P＜0.05); there was no statistical significance between the two types of patients in the abnormal signal range and cumulative score of cerebellar region (P=0.779＞0.05). The T2 sequence range and degree total score of brain MRI in patients with brain type hepatolenticular degeneration were positively correlated with the onset time (r=0.315, P=0.038), but not in patients with liver type.Conclusions Brain images of WD patients with simultaneous involvement of basal ganglia and brainstem are characteristic imaging findings both in patients of liver and brain types. The intracranial abnormal signal ratio, onset time, and the range and extent of intracranial lesions in patients brain types were higher than those in patients with liver type. Quantitative evaluation of T2 sequences is a potential evaluation method for the pathological stages and extent of the brain in WD patients.
[Keywords] hepatolenticular degeneration；clinical types；imaging features；disparity；magnetic resonance imaging

ZHAO Tieniu1, 2   LIAN Yuanshu3   HU Xuemei4   TAN Wenting5   DENG Guohong5   LIU He1   HU Xiaofei1*  

1 Department of Radiology, the First Affiliated Hospital of Army Medical University, Chongqing 400000, China

2 Department of Radiology, 924 th Hospital of the Joint Service Support Force of the People's Liberation Army, Guilin 541002, China

3 Department of Forensic surgery, 924 th Hospital of the Joint Service Support Force of the People's Liberation Army, Guilin 541002, China

4 Department of Ultrasound, 924 th Hospital of the Joint Service Support Force of the People's Liberation Army, Guilin 541002, China

5 Department of Infection, the First Affiliated Hospital of Army Medical University, Chongqing 400000, China

Hu XF, E-mail: harryzonetmmu@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  National Science and Technology Major Project During the Thirteenth Five-year Plan Period No. 2018ZX10732202 Major Technical Innovation Project of Southwest Hospital No. SWH2016ZDCX1007
Received  2020-10-20
Accepted  2021-01-21
DOI: 10.12015/issn.1674-8034.2021.03.001
Cite this article as: Zhao TN, Lian YS, Hu XＭ, et al. Clinical and MRI analysis of hepatic and cerebral hepatolenticular degeneration [J]. Chin J Magn Reson Imaging, 2021, 12(3): 1-5. DOI:10.12015/issn.1674-8034.2021.03.001.

1
Tan WT, Xiang M, Dan YJ, et al. Clinical characteristics and mutation spectrum of the pathogenic gene ATP7B in Chinese patients with Wilson's disease: analysis of 119 cases. J Third Military Medical University, 2018, 40(18): 1674-1681. DOI: 10.16016/j.1000-5404.201806104
2
Porlas Jr RV, de Castillo LLC, Dioquino CPC, et al. Neurologic wilson disease: case series on a diagnostic and therapeutic emergency. Dialogues Clin Neurosci, 2018, 20(4): 341-345. DOI: 10.31887/DCNS.2018.20.4/rporlas
3
Członkowska A, Litwin T, Dusek P, et al. Rybakowski, karl heinz weiss, michael l. schilsky. wilson disease. Nat Rev Dis Primers, 2018, 4(1): 21. DOI: 10.1038/s41572-018-0018-3
4
Guidelines for the diagnosis and treatment of Wilson's disease, Neurogenetic Diseases Group of the Chinese Medical Association Neurology Branch. Parkinson's disease and Movement disorders group of the Chinese Medical Association neurology branch. Chin J Neurol, 2008(8): 566-569.
5
Sinha S, Taly AB, Ravishankar S, et al. Wilson′s disease: cranial MRI observations and clinical correlation. Neuroradiology, 2006, 48 (9) : 613-621.
6
Anna C, Maria R, Grazyna G. Late onset Wilson's disease: therapeutic implications. Mov Disord, 2008, 23(6): 896-898. DOI: 10.1002/mds.21985
7
Hedera P. Wilson's disease: a master of disguise. Parkinsonism Relat Disord, 2019, 59: 140-145. DOI: 10.1016/j.parkreldis.2019.02.016
8
Nian YY, Meng XM, Zhang DX, et al. Clinical analysis of hepatolenticular degeneration in 111 patients. Chin J Hepatol, 2013, 21(2): 149-150.
9
Emilie F, Laurence LF, Marie C, et al. Cognitive abilities of children with neurological and liver forms of wilson disease. J Pediatr Gastroenterol Nutrit, 2017, 64(3): 436-439. DOI: 10.1097/MPG.0000000000001346
10
Samar B, Neelanjana P, Das SK. Nonmotor manifestations of Wilson's disease. Int Rev Neurobiol, 2017, 134: 1443-1459. DOI: 10.1016/bs.irn.2017.04.010
11
Zhou XX, Qin HL, He RX, et al. Clinical characteristics of patients with delayed hepatolenticular degeneration. Chin J Int Med, 2019, 58(7): 501-507. DOI: 10.3760/cma.j.issn.0578-1426.2019.07.004
12
Sauer SW, Merle U, Opp S, et al. Severe dysfunction of respiratory chain and cholesterol metabolism in Atp7b(-/-) mice as a model for Wilson disease. Biochim Biophys Acta, 2011, 1812(12): 1607-1615. DOI: 10.1016/j.bbadis.2011.08.011
13
Gerosa C., Fanni D., Congiu T. M., et al. Liver pathology in Wilson's disease: From copper overload to cirrhosis. J Inorg Biochem, 2019, 193: 106-111. DOI: 10.1016/j.jinorgbio.2019.01.008
14
Meacham KA, Cortés MP, Wiggins EM, et al. Altered zinc balance in the Atp7b-/- mouse reveals a mechanism of copper toxicity in Wilson disease. Metallomics, 2018, 10(11): 1595-1606. DOI: 10.1039/c8mt00199e
15
Alkhalik BM, Refaat R, Ahmed AF, et al. Brain magnetic resonance spectroscopy (MRS) as a diagnostic tool for detecting early neurological changes in children with Wilson's disease. Eur J Radiol, 2019, 2, (111): 41-46. DOI: 10.1016/j.ejrad.2018.12.013
16
Grupchev DI, Radeva MN, Georgieva M, et al. In vivo confocal microstructural analysis of corneas presenting Kayser-Fleischer rings in patients with Wilson's disease. Arq Bras Oftalmol, 2018, 81(2):137-143. DOI: 10.5935/0004-2749.20180030
17
Litwin T, Gromadzka G, Szpak GM, et al. Brain metal accumulation in Wilson's disease. J Neurol Sci, 2013, 329(1-2): 55-58. DOI: 10.1016/j.jns.2013.03.021
18
Ashraf A, Michaelides C, Walker TA, et al. Regional distributions of iron, copper and zinc and their relationships with glia in a normal aging mouse model. Front Aging Neurosci, 2019, 11(19): 351. DOI: 10.3389/fnagi.2019.00351
19
Zhong W, Huang ZH, Tang XQ. A study of brain MRI characteristics and clinical features in 76 cases of Wilson's disease. J Clin Neurosci, 2019, 59: 167-174. DOI: 10.1016/j.jocn.2018.10.096
20
Fernández-Rodriguez R, Contreras A, De Villoria JG, et al. Acquired hepatocerebral degeneration: clinical characteristics and MRI findings. Eur J Neurol, 2010, 17(12): 1463-70. DOI: 10.1111/j.1468-1331.2010.03076.x
21
Prashanth LK, Sinha S, Taly AB, et al. Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders?An analysis of 100 cases. Mov Disord, 2010, 25(6): 672-678. DOI: 10.1002/mds.22689
22
Ma P, Zheng B. The imaging and clinical manifestations of the intracranial lesions of hepatolenticular degeneration. J Med Imaging, 2018, 28(2): 326-328.
23
Li AP, Zhou XX, Pu XY, et al. Relationship between clinical features and abnormal signals tested by quantitative method of brain magnetic resonance imaging in Wilson disease patients. J Pract Med, 2019, 35(13): 2142-2147. DOI: 10.3969/j.issn.1006-5725.2019.13.025

PREV The principle of pH imaging with MR and its research progress on the formation mechanism and development of tumor acidic microenvironment
NEXT Clinical research of NODDI technology in deep brain nucleus of Parkinson's disease
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn